Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03519178
Title A Safety, Pharmacokinetic, Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pfizer
Indications

ovary epithelial cancer

Her2-receptor negative breast cancer

triple-receptor negative breast cancer

peritoneum cancer

fallopian tube cancer

Therapies

PF-06873600

Age Groups: adult
Covered Countries USA


No variant requirements are available.